BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Cytokine inducible SH2 containing protein (CISH; CIS; SOCS)

May 26, 2016 7:00 AM UTC

In vitro and mouse studies suggest inhibiting CISH could enhance natural killer (NK) cell-mediated antitumor immunity to treat cancer. In mouse NK cells co-cultured with a human melanoma cell line, CI...